X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
oncology (12) 12
female (11) 11
prognosis (9) 9
chemotherapy (8) 8
middle aged (8) 8
aged (7) 7
breast neoplasms - pathology (7) 7
index medicus (7) 7
adult (6) 6
breast cancer (6) 6
disease-free survival (6) 6
treatment outcome (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
breast neoplasms - therapy (5) 5
combined modality therapy (5) 5
neoplasm staging (5) 5
aged, 80 and over (4) 4
antineoplastic agents - therapeutic use (4) 4
breast neoplasms - mortality (4) 4
cancer (4) 4
cancer patients (4) 4
care and treatment (4) 4
lung neoplasms - drug therapy (4) 4
male (4) 4
piperidines - therapeutic use (4) 4
trastuzumab (4) 4
tumor angiogenesis (4) 4
carcinoma, non-small-cell lung - drug therapy (3) 3
lymphatic metastasis (3) 3
one centimeter (3) 3
paclitaxel (3) 3
quinazolines - therapeutic use (3) 3
randomized controlled trials as topic (3) 3
receptors, estrogen - analysis (3) 3
adjuvant chemotherapy (2) 2
analysis (2) 2
angiogenesis (2) 2
autologous stem cell support (2) 2
axillary lymph nodes (2) 2
breast carcinoma (2) 2
chemotherapy, adjuvant (2) 2
clinical trials as topic (2) 2
combined modality (2) 2
dosage and administration (2) 2
estrogen-receptors (2) 2
factor receptor (2) 2
follow-up studies (2) 2
head and neck neoplasms - drug therapy (2) 2
health aspects (2) 2
isolated recurrence (2) 2
kaplan-meier estimate (2) 2
less (2) 2
lung cancer (2) 2
lung neoplasms - blood (2) 2
natural-history (2) 2
neoadjuvant therapy (2) 2
original reports (2) 2
overall survival (2) 2
patient outcomes (2) 2
phase-iii (2) 2
postmenopausal women (2) 2
proportional hazards models (2) 2
prospective randomized-trial (2) 2
protein kinase inhibitors - therapeutic use (2) 2
randomized phase-ii (2) 2
receptors, vascular endothelial growth factor - antagonists & inhibitors (2) 2
recurrence (2) 2
relapse (2) 2
research (2) 2
retrospective studies (2) 2
seer program (2) 2
survival analysis (2) 2
survival rate (2) 2
tamoxifen therapy (2) 2
taxoids - administration & dosage (2) 2
tumor size (2) 2
tyrosine kinase inhibitors (2) 2
united states (2) 2
vandetanib (2) 2
vegf (2) 2
1st-line therapy (1) 1
3126 surgery, anesthesiology, intensive care, radiology (1) 1
abdominal surgery (1) 1
adjuvant therapy (1) 1
adjuvant treatment (1) 1
age (1) 1
age factors (1) 1
amplification (1) 1
angiogenesis inducing agents - blood (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
animals (1) 1
anthracyclines (1) 1
anthracyclines - therapeutic use (1) 1
anti-cd20 monoclonal-antibody (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents, hormonal - administration & dosage (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 9032 - 9032
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2010, Volume 16, Issue 4, p. 1341
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2007, Volume 25, Issue 31, pp. 4952 - 4960
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 06/2006, Volume 106, Issue 11, pp. 2327 - 2336
Journal Article
Cancer, ISSN 0008-543X, 09/2005, Volume 104, Issue 6, pp. 1158 - 1171
BACKGROUND In three prospective, single‐arm studies, the authors previously showed an improved outcome for anthracycline‐naïve patients with isolated sites of... 
Stage IV‐NED | combined modality | breast carcinoma | isolated recurrence | chemotherapy
Journal Article
Cancer, ISSN 0008-543X, 06/2006, Volume 106, Issue 11, pp. 2327 - 2336
BACKGROUND The authors previously reported results from a randomized trial of standard‐dose chemotherapy with combined 5‐fluorouracil (1000 mg/m2 per cycle),... 
overall survival | high‐dose chemotherapy | breast cancer | autologous stem cell support | recurrence‐free survival | axillary lymph nodes
Journal Article
01/2008, ISBN 1405151129, 17
This chapter contains section titled: Tumor Angiogenesis Angiogenesis in Lung Cancer Clinical Trials of Antiangiogenic Agents in the Treatment of NSCLC... 
lung cancer | therapeutic approaches | chemotherapy | angiogenesis | tumor angiogenesis | Tumor angiogenesis | Angiogenesis | Chemotherapy | Lung cancer | Therapeutic approaches
Book Chapter
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 08/2005, Volume 6, Issue 9, pp. 1477 - 1491
Journal Article
American Journal of Cancer, ISSN 1175-6357, 2006, Volume 5, Issue 6, pp. 411 - 425
Journal Article